-
Signature
-
/s/ John Faurescu, attorney-in-fact for Dr. Wierenga
-
Issuer symbol
-
CYTK
-
Transactions as of
-
28 Oct 2024
-
Net transactions value
-
-$199,806
-
Form type
-
4
-
Filing time
-
31 Oct 2024, 16:49:20 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CYTK |
Common Stock |
Options Exercise |
$32,811 |
+4,452 |
+18% |
$7.37 |
29,011 |
28 Oct 2024 |
Direct |
|
| transaction |
CYTK |
Common Stock |
Sale |
$232,617 |
-4,452 |
-15% |
$52.25 |
24,559 |
28 Oct 2024 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CYTK |
Non-Qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-4,452 |
-75% |
$0.000000 |
1,484 |
28 Oct 2024 |
Common Stock |
4,452 |
$7.37 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: